Simple timing framework Baseline Discuss baseline labs before starting or escalating, especially with diabetes, gallbladder history, pancreatitis history, kidney disease, liver disease, or cardiovascular concerns
Oral contraceptive effectiveness can be reduced during the first 4 weeks and after dose changes
Many GLP-1 users prioritize supplements that support protein intake, digestion, and micronutrient coverage
By activating GLP-1, GIP, and glucagon receptors, it enables researchers to examine how overlapping endocrine systems regulate glucose uptake, nutrient distribution, and cellular energy utilization
Retatrutide reconstitution chart Vial Size 5 mg BAC Water 1.0 mL Concentration 5 mg/mL (5,000 mcg/mL) 1 mg 0.20 mL (20 units) 2 mg 0.40 mL (40 units) 4 mg 0.80 mL (80 units) 6 mg Exceeds vial 9 mg Exceeds vial 12 mg Exceeds vial Vial Size 10 mg BAC Water 2.0 mL Concentration 5 mg/mL (5,000 mcg/mL) 1 mg 0.20 mL (20 units) 2 mg 0.40 mL (40 units) 4 mg 0.80 mL (80 units) 6 mg 1.20 mL - split draw or 2 vials 9 mg Requires 2 vials 12 mg Requires 2-3 vials Vial Size 20 mg BAC Water 2.0 mL Concentration 10 mg/mL (10,000 mcg/mL) 1 mg 0.10 mL (10 units) 2 mg 0.20 mL (20 units) 4 mg 0.40 mL (40 units) 6 mg 0.60 mL (60 units) 9 mg 0.90 mL (90 units) 12 mg 1.20 mL - split draw Vial Size 24 mg BAC Water 2.4 mL Concentration 10 mg/mL (10,000 mcg/mL) 1 mg 0.10 mL (10 units) 2 mg 0.20 mL (20 units) 4 mg 0.40 mL (40 units) 6 mg 0.60 mL (60 units) 9 mg 0.90 mL (90 units) 12 mg 1.20 mL - split draw Vial Size 30 mg BAC Water 3.0 mL Concentration 10 mg/mL (10,000 mcg/mL) 1 mg 0.10 mL (10 units) 2 mg 0.20 mL (20 units) 4 mg 0.40 mL (40 units) 6 mg 0.60 mL (60 units) 9 mg 0.90 mL (90 units) 12 mg 1.20 mL - split draw Units are U-100 insulin syringe units (1 mL = 100 units)
Learn More About Retatrutide
